An investigation of the feasibility of using a topical formulation of lidocaine (SHACT) for hysteroscopy in women To obtain initial information regarding the feasibility of using SHACT as a formulation for hysteroscopy

• Country None
• organs None
• Specialty None

An open label pharmcokinetic study of a topical formulation of lidocaine (SHACT) for pain relief in women receiving an Intra Uterine Device To establish the pharmacokinetic properties of SHACT including, AUC (0-120), Cmax and tmax, when applied in cervix and uterus of women receiving an IUD.

• Country None
• organs None
• Specialty None

A randomized, double-blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study To evaluate the maximum pain intensity experienced by the patient during and within 10 minutes after start of IUD insertion when treated with SHACT in comparison to placebo using a 100 mm VAS scale.

• Country None
• organs None
• Specialty None